Dyadic International (NASDAQ:DYAI) Share Price Passes Above Fifty Day Moving Average – Should You Sell?

Shares of Dyadic International, Inc. (NASDAQ:DYAI) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Dyadic International in a research report on Thursday, November 14th.

Dyadic International Stock Performance

The company has a current ratio of 5.15, a quick ratio of 5.15 and a debt-to-equity ratio of 1.54. The company has a market capitalization of $48.82 million, a price-to-earnings ratio of -7.17 and a beta of 0.89. The firm has a 50-day simple moving average of $1.57 and a two-hundred day simple moving average of $1.39.

Dyadic International (NASDAQ:DYAI) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.06. The business had revenue of $1.96 million for the quarter, compared to analyst estimates of $1.05 million. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. During the same quarter in the prior year, the firm posted ($0.06) EPS. As a group, sell-side analysts forecast that Dyadic International, Inc. will post -0.18 earnings per share for the current fiscal year.

Institutional Trading of Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Chapin Davis Inc. grew its position in Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 868,301 shares of the biotechnology company’s stock after acquiring an additional 21,000 shares during the quarter. Chapin Davis Inc. owned 2.97% of Dyadic International worth $903,000 as of its most recent SEC filing. Institutional investors own 27.95% of the company’s stock.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.